248 related articles for article (PubMed ID: 34109490)
21. Associations between immediate postpartum long-acting reversible contraception and short interpregnancy intervals.
Wu M; Eisenberg R; Negassa A; Levi E
Contraception; 2020 Dec; 102(6):409-413. PubMed ID: 32918870
[TBL] [Abstract][Full Text] [Related]
22. Examining the association between short interpregnancy interval births and the type and timing of postpartum long acting reversible contraception.
Rodriguez MI; Skye M; Ramanadhan S; Schrote K; Darney BG
Contraception; 2022 Aug; 112():61-67. PubMed ID: 34971615
[TBL] [Abstract][Full Text] [Related]
23. Society for Maternal-Fetal Medicine (SMFM) Consult Series #48: Immediate postpartum long-acting reversible contraception for women at high risk for medical complications.
; Vricella LK; Gawron LM; Louis JM
Am J Obstet Gynecol; 2019 May; 220(5):B2-B12. PubMed ID: 30738885
[TBL] [Abstract][Full Text] [Related]
24. Medicaid Payment For Postpartum Long-Acting Reversible Contraception Prompts More Equitable Use.
Quinlan TAG; Lindrooth RC; Guiahi M; McManus BM; Mays GP
Health Aff (Millwood); 2023 May; 42(5):665-673. PubMed ID: 37126756
[TBL] [Abstract][Full Text] [Related]
25. Medicaid Payments For Immediate Postpartum Long-Acting Reversible Contraception: Evidence From South Carolina.
Steenland MW; Pace LE; Sinaiko AD; Cohen JL
Health Aff (Millwood); 2021 Feb; 40(2):334-342. PubMed ID: 33523747
[TBL] [Abstract][Full Text] [Related]
26. Association of the affordable care act Medicaid expansions with postpartum contraceptive use and early postpartum pregnancy.
Eliason EL; Spishak-Thomas A; Steenland MW
Contraception; 2022 Sep; 113():42-48. PubMed ID: 35259409
[TBL] [Abstract][Full Text] [Related]
27. Feasibility and acceptability of a toolkit-based process to implement patient-centered, immediate postpartum long-acting reversible contraception services.
Moniz MH; Dalton VK; Smith RD; Owens LE; Landis-Lewis Z; Peahl AF; Van Kainen B; Punch MR; Wetmore MK; Bonawitz K; Kolenic GE; Dehlendorf C; Heisler M
Am J Obstet Gynecol; 2022 Mar; 226(3):394.e1-394.e16. PubMed ID: 34655551
[TBL] [Abstract][Full Text] [Related]
28. Patients' experiences with South Carolina's immediate postpartum Long-acting reversible contraception Medicaid policy.
Mann ES; White AL; Rogers PL; Gomez AM
Contraception; 2019 Aug; 100(2):165-171. PubMed ID: 31028752
[TBL] [Abstract][Full Text] [Related]
29. Review of Publicly Available State Policies for Long-Acting Reversible Contraception Device Reimbursement.
Romero L; Sappenfield OR; Uesugi K; Howland JF; Kroelinger CD; Okoroh EM; Erondu C; Cox S
J Womens Health (Larchmt); 2022 Jul; 31(7):1048-1056. PubMed ID: 35041489
[No Abstract] [Full Text] [Related]
30. Postpartum contraception method type and risk of a short interpregnancy interval in a state Medicaid population.
Gifford K; McDuffie MJ; Rashid H; Knight EK; McColl R; Boudreaux M; Rendall MS
Contraception; 2021 Sep; 104(3):284-288. PubMed ID: 34023380
[TBL] [Abstract][Full Text] [Related]
31. Special report: implementing immediate postpartum LARC in Florida.
Brown JA; Greenfield LT; Rapkin RB
Am J Obstet Gynecol; 2020 Apr; 222(4S):S906-S909. PubMed ID: 31866518
[TBL] [Abstract][Full Text] [Related]
32. Medicaid and receipt of interval postpartum long-acting reversible contraception.
Wilkinson B; Ascha M; Verbus E; Montague M; Morris J; Mercer B; Arora KS
Contraception; 2019 Jan; 99(1):32-35. PubMed ID: 30194927
[TBL] [Abstract][Full Text] [Related]
33. Postpartum long-acting reversible contraception among privately insured: U.S. National analysis 2007-2016, by term and preterm birth.
Shaw JG; Goldthwaite LM; Marić I; Shaw KA; Stevenson DK; Shaw GM
Contraception; 2023 Sep; 125():110065. PubMed ID: 37210023
[TBL] [Abstract][Full Text] [Related]
34. Provision of Immediate Postpartum Long-Acting Reversible Contraceptives Before and After Wisconsin Medicaid's Payment Change.
Kramer RD; Gangnon RE; Burns ME
Womens Health Issues; 2021; 31(4):317-323. PubMed ID: 33849768
[TBL] [Abstract][Full Text] [Related]
35. Postpartum contraception: initiation and effectiveness in a large universal healthcare system.
Brunson MR; Klein DA; Olsen CH; Weir LF; Roberts TA
Am J Obstet Gynecol; 2017 Jul; 217(1):55.e1-55.e9. PubMed ID: 28257962
[TBL] [Abstract][Full Text] [Related]
36. Condom Use With Long-Acting Reversible Contraception vs Non-Long-Acting Reversible Contraception Hormonal Methods Among Postpartum Adolescents.
Kortsmit K; Williams L; Pazol K; Smith RA; Whiteman M; Barfield W; Koumans E; Kourtis A; Harrison L; Bauman B; Warner L
JAMA Pediatr; 2019 Jul; 173(7):663-670. PubMed ID: 31107513
[TBL] [Abstract][Full Text] [Related]
37. Timing of postpartum long acting, reversible contraception was not associated with 12-month removal rates in a large Medicaid sample.
Rodriguez MI; Skye M; Samandari G; Darney BG
Contraception; 2022 Sep; 113():49-56. PubMed ID: 35378084
[TBL] [Abstract][Full Text] [Related]
38. Postpartum Contraceptive Use Among Denver-Based Adolescents and Young Adults: Association with Subsequent Repeat Delivery.
Harrison MS; Zucker R; Scarbro S; Sevick C; Sheeder J; Davidson AJ
J Pediatr Adolesc Gynecol; 2020 Aug; 33(4):393-397.e1. PubMed ID: 32251837
[TBL] [Abstract][Full Text] [Related]
39. Unmet need for postpartum long-acting reversible contraception in women with substance use disorders and/or socioeconomic disadvantage.
Best E; Lokuge B; Dunlop A; Dunford A
Aust N Z J Obstet Gynaecol; 2021 Apr; 61(2):304-309. PubMed ID: 33619725
[TBL] [Abstract][Full Text] [Related]
40. Update on incidence of inpatient tubal ligation and long-acting reversible contraception in the United States.
Fang NZ; Westhoff CL
Am J Obstet Gynecol; 2022 Sep; 227(3):477.e1-477.e7. PubMed ID: 35569515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
